- •Corneal Disease
- •Preface
- •Contents
- •Contributors
- •Core Messages
- •Organisms
- •Detection
- •Acid Fast Smears
- •Culture Media
- •Molecular Tests
- •Nucleic Acid Hybridization Probes
- •Line Probes
- •DNA Sequencing
- •FISH (Fluorescent In Situ Hybridization) Assay
- •DNA Microarray
- •Pulse Field Gel Electrophoresis (PFGE)
- •Management
- •Clinical Diagnosis
- •Medical Therapy
- •Surgical Intervention
- •Penetrating Keratoplasty
- •Corneal Cross-Linking
- •Summary for the Clinician
- •References
- •Core Messages
- •Introduction
- •Epidemiology
- •Visual Morbidity
- •Documentation
- •Causative Factors
- •Causative Bacteria
- •Investigation of Keratitis
- •Laboratory Diagnosis: Susceptibility Testing
- •Susceptibility and Resistance of Bacterial Isolates
- •Treatment: Antimicrobials
- •Current Antimicrobials in Use
- •The Fluoroquinolones
- •Aminoglycosides
- •Cephalosporins
- •Other Antimicrobials Used
- •Development of Existing and New Classes of Drugs
- •Tigecycline
- •Linezolid
- •Meropenem
- •Combination Therapy
- •Drug Delivery to the Cornea
- •Novel Methods of Drug Delivery to the Cornea
- •Conclusion
- •References
- •3: Heredity of Keratoconus
- •Introduction
- •Is Keratoconus a Heritable or Genetic Disease?
- •Mutational Screening of Candidate Genes in Keratoconus
- •Visual System Homeobox Gene 1 (VSX1)
- •Superoxide Dismutase 1 (SOD1)
- •Interleukin 1 (IL1) Superfamily
- •Collagen Genes
- •Genetic Mapping in Keratoconus
- •Genetics of Keratoconus – Mendelian or Complex?
- •References
- •4: Advance in Corneal Imaging
- •Introduction
- •In Vivo Confocal Microscopy (IVCM)
- •Principles of Confocal Microscopy
- •The Normal Cornea
- •Clinical Applications
- •Infectious Keratitis
- •Corneal Dystrophies
- •Refractive Surgery
- •Corneal Surgery
- •Other Clinical Applications
- •Limitations of IVCM
- •Anterior Segment Ocular Coherence Tomography (OCT)
- •Clinical Applications
- •Corneal Thickness Assessment
- •Refractive Surgery
- •Corneal Grafts
- •Limitations
- •Conclusion
- •References
- •Core Messages
- •Introduction
- •“Angiogenic Privilege of the Cornea” or “How Does the Normal Corneal Maintain Its Avascularity?”
- •General Mechanisms
- •Corneal Hemangiogenesis After Low-Risk Keratoplasty
- •Corneal Hemangiogenesis After High-Risk Keratoplasty
- •Corneal Lymphangiogenesis: Essential for Corneal Graft Rejection
- •Corneal Lymphangiogenesis in Dry Eye
- •Imaging of Corneal Lymphatic Vessels
- •Novel Anti(lymph)Angiogenic Treatment Options at the Cornea
- •Current Treatment Options for Immature Corneal (Blood and Lymphatic) Vessels
- •Steroids
- •Anti-VEGFs (Bevazicumab, Ranibuzumab, Pegaptanib, VEGF Trap)
- •Anti-IRS 1-Strategies (Antisense Oligonucleotides Against IRS 1)
- •Treatment Options for Mature Corneal Vessels
- •Unmet Needs and Future Directions
- •References
- •Core Messages
- •Introduction
- •Retrieval of Donor Tissue
- •Technical Aspects
- •Microbiological Aspects
- •Tissue Evaluation Aspects
- •Corneal Storage
- •Moist Chamber Storage of the Donor Eye
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Hypothermic Storage of the Corneoscleral Button
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Organ Culture (Normothermic Storage) of the Corneoscleral Button
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Other Aspects
- •Pre-cutting of Corneal Tissue for Endothelial Keratoplasty (EK)
- •Microkeratome Cutting
- •Femtosecond Laser Cutting
- •Stripping of Descemet’s Membrane with Endothelium
- •Donor Considerations for EK
- •References
- •7: Infant Keratoplasty
- •Core Messages
- •Introduction
- •Indications for Surgery
- •Visual Outcome
- •Patient Selection
- •Patient Assessment
- •Ancillary Testing
- •Donor Tissue
- •Intraoperative Considerations
- •Concurrent Surgical Procedures
- •Postoperative Considerations
- •Suture Management
- •Optical Correction and Amblyopia Therapy
- •Postoperative Complications
- •Glaucoma
- •Graft Rejection
- •Graft Failure
- •Alternatives to Penetrating Keratoplasty
- •Conclusion
- •References
- •Index
112 |
P. Kim and D.S. Rootman |
|
|
Donor Tissue
Younger donor tissue with high endothelial cell counts is ideal but often not possible due to tissue availability. Infant donor tissue (<2 years old) is not recommended as the corneal tissue is thinner and therefore makes wound closure more difficult as well as the risk of progressive ectasia and steep corneal curvatures [28]. Death to preservation time, storage to use time, or method of storage has not been shown to have any effect on graft survival [48]. There is still controversy whether HLA matching has any benefits on immune allograft rejection and graft survival [22, 47]. However, ABO matching may have some benefit [47].
Intraoperative Considerations
Penetrating keratoplasty is performed under general anesthesia. The surgery is technically more difficult as the infant eye is smaller and the palpebral fissure is narrower. Occasionally, a lateral canthotomy may be required to improve surgical access.
Although similar to adult penetrating keratoplasty, certain important surgical modifications are required. A smaller sized graft is required, usually 6–7 mm, but occasionally smaller, to avoid sutures encroaching onto the limbus [40]. This will also keep the graft/host margin away from the limbus that may prevent peripheral anterior synechia from forming. Oversizing the donor tissue by 0.5–1.0 mm is recommended as this assists in wound closure as well as increasing anterior chamber depth [49]. The donor corneal button should be prepared prior to excising the host anterior chamber. An intracameral miotic should also be instilled if lensectomy is not planned to protect the crystalline lens.
The risk of lens extrusion and suprachoroidal hemorrhage is increased in infant keratoplasty secondary to decreased scleral rigidity and increased posterior vitreous pressure (Fig. 7.1) [11, 40]. It is important to use a Flieringa ring or an equivalent to stabilize the globe, taking care not to inadvertently perforate the thin infant sclera (Fig. 7.2) [13]. The suture ends may be left long and taped to the drapes. Superior and inferior rectus bridle sutures may offer additional control of the globe. Other techniques include the use of non-depolarizing muscle relaxants to eliminate the risk of extraocular muscle contraction during the surgical procedure; positioning the patient in a slight head down position; controlled hyperventilation; intravenous mannitol 20% (0.5–1.5 g/kg), and preoperative ocular massage [18, 36, 41].
As the infant cornea is thinner and more pliable than in adults, suturing and tissue apposition is more difficult [11]. Once the recipient corneal button has been excised, it is important to suture the donor button efficiently. Preplaced mattress bridge sutures may be placed before trephination and used to hold the donor cornea in place while it is positioned and cardinal sutures placed [37]. To prevent postoperative pupillary block, peripheral iridectomies (PIs) should be performed. In Peter’s anomaly, where there may be preexisting iridocorneal adhesions, it is important to perform four PIs. In this circumstance, PAS are likely to form, and the PIs tend to
7 Infant Keratoplasty |
113 |
|
|
Fig. 7.2 This color photograph shows the operative set-up prior to performing penetrating keratoplasty. A Flieringa ring is placed and the suture ends left long and taped to the drapes. Using tape rather than hemostats greatly reduces the amount of hardware present close to the operative field. A superior and inferior rectus bridle suture is also present and the cornea has been
marked with an 8-zone marker
Fig. 7.3 Intraoperative lens extrusion following trephination of the recipient
limit progressive PAS in the postoperative period. Additionally, at the time of surgery, viscoelastic can be injected through a small paracentesis, and lyse any preexisting iridocorneal adhesions. This is much easier than trying to lyse the adhesions once the eye is “open sky” as the iris and/or lens often bulges forward (Fig. 7.3).
A watertight wound is critical at the conclusion of surgery and more than 16 sutures may be required to achieve this. The use of interrupted 10-0 nylon sutures is recommended. This ensures good wound closure with the thin infant recipient cornea. Additionally, if sutures loosen, break, or erode, they can be removed more
